
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lamivudine | FAERS: 18 | US FAERS | |
| 2 | Tacrolimus | FAERS: 3 | US FAERS | |
| 3 | Azithromycin | FAERS: 1 | US FAERS | |
| 4 | Cyclophosphamide | FAERS: 1 | US FAERS | |
| 5 | Mirtazapine | FAERS: 1 | US FAERS | |
| 6 | entecavir | FAERS: 1 | US FAERS | |
| 7 | Bosentan | OFFSIDES | ||
| 8 | Didanosine | OFFSIDES | ||
| 9 | Nelfinavir | OFFSIDES | ||
| 10 | Remifentanil | OFFSIDES | ||
| 11 | Stavudine | OFFSIDES | ||
| 12 | Tenofovir | OFFSIDES | ||
| 13 | Valacyclovir | OFFSIDES | ||
| 14 | Vinblastine | OFFSIDES | ||
| 15 | abacavir | OFFSIDES | ||
| 16 | geranylgeranylacetone | OFFSIDES |
| Name | Semantic Similarity | |
|---|---|---|
| 1 | Hepatitis C virus | |
| 2 | Hepatitis A Virus | |
| 3 | Hepatitis B Virus |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120267
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.